While most studies reported that corticosteroid, in general, inhibits IL-4 signaling by downregulating the IL-4 receptor and STAT6 activity [82], others suggest an increase in some related proteins, such as IL-13, in the DMD group treated with steroids [83]. Here, STAT6 is linked to Duchenne muscular dystrophy.